Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treating Leg Symptoms in Women with X-linked Adrenoleukodystrophy
2024-518989-27-01Phase 4Completed
- Sponsor
- Amsterdam University Medical Center
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of pramipexole in adrenoleukodystrophy (ALD) and restless legs syndrome (RLS) (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: Subjective total sleep time, Subjective sleep latency and 7 more. Started Dec 2024; status: completed.
02
Drugs
pramipexole
03
Conditions
adrenoleukodystrophy (ALD)restless legs syndrome (RLS)
Beyond the preview
Go deeper on 2024-518989-27-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-518989-27-01.